Skip to content
Review Open access

Tales of destruction and repair: the changing view of MYC proteins in tumorigenesis.

Sep 2026 · Genes & Development · 0 citations
Medicine

TL;DR

Findings suggest that, through these activities, MYC proteins enhance the stress resilience of proliferating cells and enable tumor cells to sustain nonphysiological, oncogenic gene expression programs.

Abstract

MYC proteins are classically viewed as oncoproteins because they act as DNA-bound transcription factors that drive characteristic gene expression programs. Building on this view, recent work has shown that MYC proteins engage in multiple protein complexes that resolve transcription-associated stress and that they function as both DNA- and RNA-binding proteins. These findings suggest that, through these activities, MYC proteins enhance the stress resilience of proliferating cells and enable tumor cells to sustain nonphysiological, oncogenic gene expression programs.

Read PDF

Similar papers

Review Open access Sep 2026

Hypertranscription: the invisible hand in cancer epigenetics

Global upregulation of transcription, or hypertranscription, is observed in most human cancers, driven by the action of oncogene-encoded transcription factors (TFs). TF interactions with RNA Polymerase II (Pol II) are mediated by kinases that phosphorylate the Pol II C-terminal domain (CTD) to drive productive elonga...

S. Henikoff, Robert N. Eisenman, K. Ahmad · 0 citations
Review Open access Sep 2026

A guide to transcriptional cyclin-dependent kinases in cancer.

Transcriptional cyclin-dependent kinases (tCDKs) are master regulators of gene expression, controlling RNAPII activity and RNA synthesis across multiple phases of the transcription cycle. While highly controlled transcription is essential for all cellular processes and functions, aberrant gene expression or corrupted a...

J. Devlin, Salla Kyheröinen, Ricky W. Johnstone · 0 citations
Open access Sep 2026

Post-translational modifications of KRAS: from molecular regulation to therapeutic targeting

: The rat sarcoma virus (RAS) proteins are small GTPases that regulate cell signaling and are frequently mutated in human cancers. Their activity is mainly controlled by cycling between guanosine diphosphate (GDP)-bound and guanosine triphosphate (GTP)-bound states, which is regulated by guanine nucleotide exchange fac...

Ni Yao, Lu Yang, Ran-Ran Zhou et al. · 0 citations
Review Open access Oct 2026

New insights into FOX proteins in cancer.

Forkhead box (FOX) proteins are transcription factors whose dysregulation drives tumor initiation, metastasis, and therapy resistance, yet their direction of effect is determined by cellular context rather than by their conserved DNA-binding domain. Applying explicit criteria across all 44 human members, we find contex...

Sara Alrawashdeh, Gazia Buzaakuk, Raghd Obidat et al. · 0 citations
Review Open access Sep 2026

Cancer-associated synonymous mutations target mRNA structures and protein activity.

The role of adaptive mRNA structures in regulating gene expression in mammalian cells remains poorly understood. Synonymous mutations have been linked to a range of diseases, including cancer, yet their impact on cell biology remains largely unexplored. This opinion focuses on how cancer-associated synonymous mutations...

Robin Fåhraeus · 0 citations
Review Open access Sep 2026

Nucleoporins in Cancer: Functional Roles and Therapeutic Opportunities

The nuclear pore complex (NPC) and its building-block proteins nucleoporins (NUPs) play fundamental roles in maintaining cellular fitness by regulating nucleocytoplasmic transport, chromatin and transcriptional activity, and genome stability. These core biological processes are critical for cancer cells, and thus tumor...

Perumalraja Kirthika, Vijayakumar Jawalagatti, M. Carceles-Cordon et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.